Page last updated: 2024-09-02

gr 127935 and 5-chloro-2,3-dihydro-6-(4-methylpiperazin-1-yl)-1-(4-(pyridin-4-yl)naphth-1-ylaminocarbonyl)-1h-indole

gr 127935 has been researched along with 5-chloro-2,3-dihydro-6-(4-methylpiperazin-1-yl)-1-(4-(pyridin-4-yl)naphth-1-ylaminocarbonyl)-1h-indole in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordon, LJ; Harrington, FP; Hopley, SC; Scott, CM; Ward, SE; Watson, JM1

Other Studies

1 other study(ies) available for gr 127935 and 5-chloro-2,3-dihydro-6-(4-methylpiperazin-1-yl)-1-(4-(pyridin-4-yl)naphth-1-ylaminocarbonyl)-1h-indole

ArticleYear
Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.
    Journal of medicinal chemistry, 2005, May-19, Volume: 48, Issue:10

    Topics: Animals; Binding, Competitive; Cerebral Cortex; CHO Cells; Cricetinae; Cricetulus; In Vitro Techniques; Piperazines; Quinolines; Radioligand Assay; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Structure-Activity Relationship

2005